Prezzo di chiusura
Altri mercati azionari
|
Variaz. 5gg | Var. 1 gen. | ||
- PTS | -.--% | -.--% | -.--% |
14/05 | Transcript : Nykode Therapeutics AS, Q1 2024 Earnings Call, May 14, 2024 | |
14/05 | Nykode Therapeutics AS riporta i risultati degli utili per il primo trimestre conclusosi il 31 marzo 2024 | CI |
Attività
Vendite per attività
NOK in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Novel Vaccines and Immunotherapies
100,0
%
| 69 | 100,0 % | 136 | 100,0 % | +97,76% |
Vendite per regione
NOK in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 69 | 100,0 % | 136 | 100,0 % | +97,76% |
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Founder | 47 | 01/01/07 | |
Michael Engsig
CEO | Chief Executive Officer | - | 01/03/07 |
Harald Gurvin
DFI | Director of Finance/CFO | 49 | 03/05/21 |
Chief Tech/Sci/R&D Officer | 50 | 01/06/21 | |
Chief Tech/Sci/R&D Officer | - | 01/08/17 | |
Siri Torhaug
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/20 |
Mette Husbyn
CTO | Chief Tech/Sci/R&D Officer | - | 01/10/17 |
Mona Welschof
CTO | Chief Tech/Sci/R&D Officer | - | 01/10/13 |
Louise Stubbe
LAW | General Counsel | - | 01/01/22 |
Peter Fatum
PRN | Corporate Officer/Principal | - | 01/01/21 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Bernd Seizinger
BRD | Director/Board Member | 67 | - |
Director/Board Member | 64 | - | |
Director/Board Member | - | - | |
Chairman | 69 | 22/12/21 | |
Director/Board Member | 56 | - | |
Birgitte Volck
BRD | Director/Board Member | 61 | 05/05/21 |
Director/Board Member | 52 | - | |
Anders Tuv
BRD | Director/Board Member | 46 | - |
Elaine Sullivan
BRD | Director/Board Member | 63 | 13/05/22 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 326 546 444 | 179 598 448 ( 55,00 %) | 0 | 55,00 % |
Coordinate società
Nykode Therapeutics ASA
Oslo Science Park Gaustadalléen 21
0349, Oslo
+47 22 95 81 93
http://www.nykode.comSettore
Vendite per regione
Revisioni EPS
Variaz. 1 gen. | Capi. | |
---|---|---|
+11,91% | 114 Mrd | |
+11,60% | 105 Mrd | |
-4,68% | 23,83 Mrd | |
-0,82% | 21,73 Mrd | |
-10,12% | 18,1 Mrd | |
-42,12% | 16,34 Mrd | |
-17,47% | 16,13 Mrd | |
+2,77% | 13,75 Mrd | |
+34,58% | 11,76 Mrd |
- Borsa valori
- Azioni
- Azione NYKD
- Azione VACC
- Società VACY AS